10 Hot Stocks to Watch — Wednesday, September 9, 2026

Intel jumped 9.05% to $104.47 as semiconductor peers rally on manufacturing breakthroughs and strong AI infrastructure demand. Options traders are betting on continued strength, with call-to-put ratio at 2.51 and heavy volume across $105–$110 strikes expiring this week and next, signaling conviction above current levels. Watch the $105 support and $110 resistance; a breach of the latter would validate near-term bullish positioning ahead of potential foundry customer wins in 2027.

AMD rallied 5.9% to $505.74 as semiconductor tailwinds from AI infrastructure demand and Qualcomm's AWS partnership lifted the chip sector. Heavy call buying—highlighted by a 3.13 call-to-put ratio and nearly 21,000 contracts at the $500 strike—signals options traders expect the chip maker to test $515–$520 near-term. With TSMC packaging constraints potentially opening doors for AMD's foundry relationships by 2027, bulls are positioning for sustained momentum ahead of earnings.

ServiceNow shares fell 4.99% today as institutional clients rotated out of software names including NOW, CRM, and ORCL amid geopolitical tensions and inflation concerns. However, options markets paint a starkly different picture: call volume surged to 2.09 call-to-put ratio, with heavy positioning in $140 calls across September expiries suggesting traders are buying the dip ahead of support. Watch the $130 level—put volume of nearly 2,000 contracts signals conviction that NOW holds this floor through mid-September.

BioNTech fell 4.92% today after halting a mid-stage personalized mRNA cancer vaccine trial, prompting BMO Capital to downgrade the stock to Market Perform and cut its price target to $105 from $128. The setback arrives as peer Moderna surges 143% on rival cancer therapy wins, highlighting execution risk in the crowded mRNA space. Options traders remain hedged: heavy put volume at $85 (1,018 contracts) and $55 strikes through 2026 suggests downside protection, while scattered calls above $120 imply limited conviction on near-term recovery.

Zscaler fell 4.63% today as FY27 guidance disappointed despite Q4 beat, signaling decelerating ARR growth that unnerved the Street. Yet options traders are painting a contrarian picture: call volume surged with 3.60 call-to-put ratio, particularly at $170 and $190 strikes expiring mid-September, suggesting conviction in a near-term bounce. Broader sector weakness from Middle East tensions and inflation fears added to headwinds. Watch the $170 level by Sept. 11—if ZS reclaims it, options flow could validate.

Intuitive Surgical fell 4.51% to $350.16 today, bucking positive clinical validation showing da Vinci robotic surgery outperforms traditional methods across 13 procedures. BTIG maintains a $469 price target, yet the selloff suggests profit-taking or broader medtech sector pressure. Options flow shows heavy call volume at $350/$360 strikes expiring Sept. 11, with traders apparently testing support near today's close, while put positioning ($330/$345) hints at downside hedging ahead of next week's expiry.

Lam Research jumped 4.15% to $320.42 today, extending a six-month rally of 45.5% as semiconductor equipment makers benefit from record AI infrastructure spending. The Qualcomm-AWS announcement and ASML/TSMC manufacturing milestones reignited appetite for process-control gear. Options markets show mixed conviction: heavy call volume at $335–$345 strikes (September 18 expiry) suggests upside bets, but put protection at $250 indicates traders hedging against a correction from the stock's $438.50 near-term high.

Tesla rallied 3.98% to $368.16 as Goldman Sachs validated the Cybercab's competitive edge, estimating 30-cent-per-mile cost savings over Waymo while ARK flagged potential fares 50% below Uber. The move spooked Uber, which fell 4%, signaling investor conviction in Tesla's autonomous ambitions. Options markets are pricing aggressively bullish conviction: a 2.14 call-to-put ratio and 182k-contract volume in the $370 Sept 9 calls suggest traders see further upside, with resistance at $375–$380 critical to watch.

Robinhood shares declined 3.91% today despite Jefferies raising its price target to $140, implying nearly 20% upside from current levels and reaffirming a Buy rating. The call-heavy options market—with a 1.95 call-to-put ratio and over 10,900 contracts at the $125 strike expiring September 2026—suggests institutional conviction in a recovery. Traders are positioning for a move back toward the $125–$130 range, though near-term headwinds from the AMC tokenization spat and broader financial sector weakness merit caution.

Salesforce dropped 3.9% today, joining a broader software selloff as institutional investors rotate into chip and aerospace plays like Nvidia and SpaceX. The Dow Jones US Software Index has plunged 36% from its October peak, signaling renewed anxiety about AI disruption despite recent rallies in NOW and SNOW. Options markets show heavy put interest at $245 (5,454 contracts), suggesting traders are hedging downside through September, while call volumes lag—a bearish divergence as CRM approaches its $269 52-week high.